Pure Global AI
NCT06343181Recruiting

A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer

European Institute of OncologyClinicalTrials.gov
Verified
Study focus
Disease/Condition
Metastatic Breast Cancer
Study type
Observational
Sponsor & location
Primary sponsor
European Institute of Oncology
Location
Milan, Italy
Timeline & enrollment
Phase
N/A
Start date
Oct 03, 2022
End date
Dec 31, 2024
Enrollment
20 participants
Primary outcome

Evaluation of factors influencing patients' adherence to medical therapy

Summary

Qualitative observational study with the aim to explore medication adherence in a sample of
 patients with metastatic breast cancer.
 
 Patients with metastatic breast cancer receiving or having received oral oncologic therapy,
 and attending the Division of Medical Senology at the European Institute of Oncology, will be
 included and enrolled in this research project.

ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedMalignant neoplasm: Central portion of breastMalignant neoplasm: Overlapping lesion of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06343181
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06343181 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Metastatic Breast Cancer. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.